Relational Agents in Cervical Cancer Education (RACE)
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 91
- Locations
- 2
- Primary Endpoint
- Participation Rate
Study Overview
Brief Summary
The goal of this clinical trial is to assess the feasibility of using interactive teaching to educate cervical cancer patients about Human papillomavirus (HPV) and HPV vaccinations.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Health Services Research
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- Female
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Adults aged 18 and older
- •Patients with an ICD9 diagnosis of cervical/vaginal/vulvar cancer or dysplasia receiving care at Karmanos Cancer Institute or OU Health Stephenson Cancer Center
Exclusion Criteria
- •Patients who are recorded in the EHR as requesting to be removed from research
- •Non-English speakers
- •Any cognitive disability that prevents informed consent
- •Any individual recruited in previous phases of the Study will be excluded.
Arms & Interventions
Control
The control group will be given a standardized handout
Intervention: Control (Other)
Intervention
The intervention group will be shown an educational video
Intervention: Intervention (Other)
Outcomes
Primary Outcomes
Participation Rate
Time Frame: Up to 6 weeks
The Ratio of the number of participants to the number of patients asked to join the clinical trial
Survey Completion Rate
Time Frame: Up to 6 Weeks
The Ratio of the number of participants who complete the survey to the number of participants overall.
Secondary Outcomes
- Change in intention to discuss HPV vaccination(Up to 6 weeks)
- Change in social norms and behaviors(Up to 6 weeks)
- Change in Stigma(Up to 6 weeks)
- Change in Health Literacy(Up to 6 weeks)
Investigators
Radhika Gogoi
Principal Investigator, Associate Professor
Barbara Ann Karmanos Cancer Institute
